Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon
Adrian M. Di Bisceglie, Vinod K. Rustgi, Chris Kassianides, Mauricio Lisker‐Melman, Yoon Park, Jeanne G. Waggoner, Jay H. Hoofnagle – 1 February 1990 – Eight patients with chronic hepatitis B entered a pilot study of gamma interferon and alpha interferon in combination. Gamma interferon alone had minimal inhibitory effects on serum levels of hepatitis B virus as monitored by serum HBV DNA and DNA‐polymerase activity. The drug also gave troublesome side effects. In contrast, alpha interferon had more potent inhibitory effects on serum HBV levels and fewer side effects.